Terms: = Leukemia AND ATF1, TREB36, 466, ENSG00000123268, P18846
110 results:
1. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic leukemia].
Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
[TBL] [Abstract] [Full Text] [Related]
4. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
[TBL] [Abstract] [Full Text] [Related]
5. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract] [Full Text] [Related]
6. Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Visram A; De La Torre A; White D; Su J; Masih-Khan E; Chu M; Jimenez-Zepeda V; McCurdy A; LeBlanc R; Song K; Mian H; Louzada M; Sebag M; Bergstrom D; Stakiw J; Reiman A; Kotb R; Aslam M; Venner C; Kaedbey R; Gul E; Reece D
Blood Cancer J; 2023 Dec; 13(1):181. PubMed ID: 38065967
[TBL] [Abstract] [Full Text] [Related]
7. [Interim results of a multicenter cohort study for Chinese Children leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
8. Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes.
Bashi MA; Ad'hiah AH
Cytokine; 2023 Nov; 171():156368. PubMed ID: 37716188
[TBL] [Abstract] [Full Text] [Related]
9. Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract] [Full Text] [Related]
10. Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma.
Inoue Y; Morishima S; Kato K; Ito A; Nakano N; Kuriyama T; Kawakita T; Mori Y; Suehiro Y; Itonaga H; Miyazaki Y; Imada K; Tomori S; Kanda J; Ichinohe T; Atsuta Y; Fukuda T; Yoshimitsu M;
Bone Marrow Transplant; 2023 Sep; 58(9):980-990. PubMed ID: 37173417
[TBL] [Abstract] [Full Text] [Related]
11. MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis.
Yang Y; Qiu R; Weng Q; Xu Z; Song J; Zhao S; Meng M; Zhang D; Kong C; Wang H; Xu M; Zhao Z; Ji J
Cancer Res Treat; 2023 Jul; 55(3):778-803. PubMed ID: 36701842
[TBL] [Abstract] [Full Text] [Related]
12. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
13. Evidence-based support for phenotypic drug discovery in acute myeloid leukemia.
Vandersluis S; Reid JC; Orlando L; Bhatia M
Drug Discov Today; 2022 Dec; 27(12):103407. PubMed ID: 36243303
[TBL] [Abstract] [Full Text] [Related]
14. Nontyphoidal
Yun CH; Kao WC; Hsu CY; Chang R; Cheng MF; Hung YM
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232242
[TBL] [Abstract] [Full Text] [Related]
15. THE OVERWEIGHT AND OBESITY ROLE IN THE OCCURRENCE OF CHEMOTHERAPY-INDUCED HEPATOTOXIC REACTIONS IN PATIENTS WITH ACUTE MYELOID leukemia.
Skrypnyk IМ; Maslova GS; Lymanets TV; Skrypnyk RІ
Wiad Lek; 2022; 75(6):1506-1511. PubMed ID: 35907224
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract] [Full Text] [Related]
17. NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.
Hwang WL; Chen TC; Lin HY; Chang MC; Hsiao PC; Bai LY; Kuo CY; Chen YC; Liu TC; Gau JP; Wang PN; Hwang WS; Kuo MC; Liu CY; Liu YC; Ma MC; Su NW; Wang CC; Wu YY; Yao M; Yeh SP; Cheng HW; Lee YM; Ku FC; Tang JL
Int J Hematol; 2022 May; 115(5):704-712. PubMed ID: 35212915
[TBL] [Abstract] [Full Text] [Related]
18. Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid leukemia in Need of Chemotherapy Augmentation.
Elsayed AH; Cao X; Mitra AK; Wu H; Raimondi S; Cogle C; Al-Mansour Z; Ribeiro RC; Gamis A; Kolb EA; Aplenc R; Alonzo TA; Meshinchi S; Rubnitz J; Pounds S; Lamba JK
J Clin Oncol; 2022 Mar; 40(7):772-783. PubMed ID: 34990262
[TBL] [Abstract] [Full Text] [Related]
19. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
Horný M; Shafer PR; Dusetzina SB
JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
[TBL] [Abstract] [Full Text] [Related]
20. Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Xu Q; He S; Yu L
Front Immunol; 2021; 12():683595. PubMed ID: 34484181
[TBL] [Abstract] [Full Text] [Related]
[Next]
